('e-Therapeutics' or 'the Company')

First Day of Dealings on AIM

A placing of 1,985,075 Ordinary Shares at 67 pence each has raised 1.33 million
(gross) for the Company. The total issued share capital of the Company is
55,710,103 and the market capitalisation of the Company at the Placing Price
following Admission will be 37.33 million.

Commenting on the Placing and Admission, Professor Malcolm Young, Chief
Executive Officer of e-Therapeutics, said: 'We are delighted by the response of
investors to the flotation of e-Therapeutics. The funds raised will enable us to
develop and broaden our drug development pipeline, and will significantly raise
the profile of e-Therapeutics with potential licensing partners. I would like to
thank all of our investors for recognising the exciting opportunity that lies
ahead.'

The directors of e-Therapeutics plc (AIM: ETX), Advanced Cell Technology (OTCBB: ACTC), Kiotech International (AIM: KIO) and Camco International (AIM: CAO) will be presenting:

Thursday the 14th October 2010, Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB

The presentations will start at 6:00pm and finish at approx 8:00pm. After the presentations are complete the directors will also be available to take questions during a free canapand wine reception. Details on the presenting companies can be found below.

This event is suitable for the following: Sophisticated & private investors, private client brokers, fund managers, financial institutions, hedge funds, buy & sell side analysts and journalists.

FREE registration - http://www.proactiveinvestors.co.uk/register/event_details/90

If you have any problems registering or queries please email events@proactiveinvestors.com.

The directors of Lo-Q (AIM: LOQ), e-Therapeutics plc (AIM: ETX), Asterand (LSE: ATD) and Norcon Plc (AIM: NCON) will be presenting:
Thursday the 3rd March 2011, Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB

The presentations will start at 6:00pm and finish at approx 8.00pm. After the presentations are complete the directors will also be available to take questions during a free canapand wine reception. Details on the presenting companies can be found below.

This event is suitable for the following:
Sophisticated & private investors, private client brokers, fund managers, financial institutions, hedge funds, buy & sell side analysts and journalists.

FREE registration - http://www.proactiveinvestors.co.uk/register/event_details/102

If you have any problems registering or queries please email events@proactiveinvestors.com.au.

Came across this audio interview with E- THERAPEUTICS.

Take a look:

http://www.brrmedia.co.uk/event/98793/daniel-elger-chief-financial-officer